Research grant
CRI Lloyd J. Old STAR Program
Cancer Research Institute
- , Add deadline: choose a calendar
- Up to $1,250,000
- Early independent researcher · Mid-career researcher
- Worldwide
- Apply directly
- Cancer Biology, Immunology and
About
Long-term, flexible funding for mid-career scientists pursuing high-risk, high-reward research at the leading edge of cancer immunotherapy. STAR (Scientists TAking Risks) awards support an investigator's body of work rather than a single project, for scientists who frame significant, non-obvious questions, connect disciplines to generate and test new hypotheses, and pursue unconventional lines of inquiry in fundamental or translational cancer immunology. Shortlisted candidates are interviewed by leaders of CRI's Scientific Advisory Council.
Topics
- cancer immunotherapy, search World Wide
- STAR (Scientists TAking Risks), search World Wide
- cancer immunology, search World Wide
- mid-career scientists, search World Wide
- high-risk, high-reward research, search World Wide
- Long-term, flexible funding, search World Wide
- investigator's body of work, search World Wide
- translational cancer immunology, search World Wide
Eligibility
Covers: US$1.25 million over five years, not tied to a single project; indirect costs of up to 10% are provided in addition. Awards activate no earlier than 1 July.
Medical schools and research centres in the United States or abroad; for-profit institutions are not supported.
Nationality or residence: No citizenship restrictions.
Applicants need an M.D., Ph.D. or M.D./Ph.D. (or equivalent) and a tenure-track position: assistant professors with at least three years in that role (appointed on or before 1 July 2024 for the January 2027 deadline) or associate professors with at most three years in that role (appointed on or after 1 July 2024). Adjunct and acting positions are not eligible, and awardees commit at least 80% of their time to research. There are no citizenship restrictions; research may be conducted in the United States or abroad, but not at for-profit institutions.
Source: cancerresearch.org